Munoz-Galvan S, Verdugo-Sivianes E, Santos-Pereira J, Estevez-Garcia P, Carnero A
J Exp Clin Cancer Res. 2024; 43(1):57.
PMID: 38403587
PMC: 10895852.
DOI: 10.1186/s13046-024-02988-y.
Lee Y, Shin K, Jang H, Noh D, Ryu S, Suh P
Adv Exp Med Biol. 2021; 1187:23-52.
PMID: 33983572
DOI: 10.1007/978-981-32-9620-6_2.
McDermott M, Wang Y, Wakelam M, Bankaitis V
Prog Lipid Res. 2019; 78:101018.
PMID: 31830503
PMC: 7233427.
DOI: 10.1016/j.plipres.2019.101018.
Munoz-Galvan S, Lucena-Cacace A, Perez M, Otero-Albiol D, Gomez-Cambronero J, Carnero A
Oncogene. 2018; 38(8):1309-1323.
PMID: 30305726
DOI: 10.1038/s41388-018-0527-2.
Zamani A, Decker C, Cremasco V, Hughes L, Novack D, Faccio R
J Bone Miner Res. 2015; 30(10):1852-63.
PMID: 25891971
PMC: 4580562.
DOI: 10.1002/jbmr.2533.
Phospholipase D signaling pathways and phosphatidic acid as therapeutic targets in cancer.
Bruntz R, Lindsley C, Brown H
Pharmacol Rev. 2014; 66(4):1033-79.
PMID: 25244928
PMC: 4180337.
DOI: 10.1124/pr.114.009217.
Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR).
Foster D, Salloum D, Menon D, Frias M
J Biol Chem. 2014; 289(33):22583-22588.
PMID: 24990952
PMC: 4132766.
DOI: 10.1074/jbc.R114.566091.
A GEF-to-phospholipase molecular switch caused by phosphatidic acid, Rac and JAK tyrosine kinase that explains leukocyte cell migration.
Mahankali M, Henkels K, Gomez-Cambronero J
J Cell Sci. 2013; 126(Pt 6):1416-28.
PMID: 23378025
PMC: 3644142.
DOI: 10.1242/jcs.117960.
Phospholipase signalling networks in cancer.
Park J, Lee C, Jang J, Ghim J, Kim Y, You S
Nat Rev Cancer. 2012; 12(11):782-92.
PMID: 23076158
DOI: 10.1038/nrc3379.
Phospholipase D controls Dictyostelium development by regulating G protein signaling.
Ray S, Chen Y, Ayoung J, Hanna R, Brazill D
Cell Signal. 2010; 23(2):335-43.
PMID: 20950684
PMC: 3013293.
DOI: 10.1016/j.cellsig.2010.09.017.
Heterogeneity of phosphatidic acid levels and distribution at the plasma membrane in living cells as visualized by a Föster resonance energy transfer (FRET) biosensor.
Nishioka T, Frohman M, Matsuda M, Kiyokawa E
J Biol Chem. 2010; 285(46):35979-87.
PMID: 20826779
PMC: 2975220.
DOI: 10.1074/jbc.M110.153007.
New concepts in phospholipase D signaling in inflammation and cancer.
Gomez-Cambronero J
ScientificWorldJournal. 2010; 10:1356-69.
PMID: 20623096
PMC: 3070604.
DOI: 10.1100/tsw.2010.116.
PLD2 has both enzymatic and cell proliferation-inducing capabilities, that are differentially regulated by phosphorylation and dephosphorylation.
Henkels K, Short S, Peng H, Fulvio M, Gomez-Cambronero J
Biochem Biophys Res Commun. 2009; 389(2):224-8.
PMID: 19715678
PMC: 2754605.
DOI: 10.1016/j.bbrc.2009.08.109.
Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.
Foster D
Biochim Biophys Acta. 2009; 1791(9):949-55.
PMID: 19264150
PMC: 2759177.
DOI: 10.1016/j.bbalip.2009.02.009.
In skeletal muscle advanced glycation end products (AGEs) inhibit insulin action and induce the formation of multimolecular complexes including the receptor for AGEs.
Cassese A, Esposito I, Fiory F, Barbagallo A, Paturzo F, Mirra P
J Biol Chem. 2008; 283(52):36088-99.
PMID: 18955497
PMC: 2662288.
DOI: 10.1074/jbc.M801698200.
Mutation of Y179 on phospholipase D2 (PLD2) upregulates DNA synthesis in a PI3K-and Akt-dependent manner.
Fulvio M, Frondorf K, Gomez-Cambronero J
Cell Signal. 2007; 20(1):176-85.
PMID: 18006275
PMC: 2276604.
DOI: 10.1016/j.cellsig.2007.10.009.
Requirement of phospholipase D1 activity in H-RasV12-induced transformation.
Buchanan F, McReynolds M, Couvillon A, Kam Y, Holla V, DuBois R
Proc Natl Acad Sci U S A. 2005; 102(5):1638-42.
PMID: 15668389
PMC: 547811.
DOI: 10.1073/pnas.0406698102.
Phospholipase D elevates the level of MDM2 and suppresses DNA damage-induced increases in p53.
Hui L, Abbas T, Pielak R, Joseph T, Bargonetti J, Foster D
Mol Cell Biol. 2004; 24(13):5677-86.
PMID: 15199126
PMC: 480910.
DOI: 10.1128/MCB.24.13.5677-5686.2004.
Elevated phospholipase D activity in H-Ras- but not K-Ras-transformed cells by the synergistic action of RalA and ARF6.
Xu L, Frankel P, Jackson D, Rotunda T, Boshans R, DSouza-Schorey C
Mol Cell Biol. 2003; 23(2):645-54.
PMID: 12509462
PMC: 151535.
DOI: 10.1128/MCB.23.2.645-654.2003.
Role for phospholipase D in receptor-mediated endocytosis.
Shen Y, Xu L, Foster D
Mol Cell Biol. 2001; 21(2):595-602.
PMID: 11134345
PMC: 86627.
DOI: 10.1128/MCB.21.2.595-602.2001.